BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6608343)

  • 1. Cefonicid concentrations in human aqueous humor.
    Axelrod JL; Kochman RS
    Arch Ophthalmol; 1984 Mar; 102(3):433-4. PubMed ID: 6608343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefamandole levels in primary aqueous humor in man.
    Axelrod JL; Kochman RS
    Am J Ophthalmol; 1978 Mar; 85(3):342-8. PubMed ID: 306752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
    Fourtillan JB; Leroy A; Lefebvre MA; Humbert G; Fillastre JP; Reumont G; Ramis N
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):225-30. PubMed ID: 3936717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN; Quintiliani R; Nightingale CH
    Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
    Chemioterapia; 1987 Apr; 6(2):95-8. PubMed ID: 3594635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of cefonicid into human breast milk and various body fluids and tissues.
    Lou MA; Wu YH; Jacob LS; Pitkin DH
    Rev Infect Dis; 1984; 6 Suppl 4():S816-20. PubMed ID: 6522923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
    Geckler RW; McCormack GD; Goodman JS
    Rev Infect Dis; 1984; 6 Suppl 4():S847-52. PubMed ID: 6395275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
    Furlan G; Besa G; Broccali G; Gusmitta A
    Int J Clin Pharmacol Res; 1989; 9(1):49-53. PubMed ID: 2707925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
    Dudley MN; Shyu WC; Nightingale CH; Quintiliani R
    Antimicrob Agents Chemother; 1986 Oct; 30(4):565-9. PubMed ID: 3789691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
    Phelps RT; Conte JE
    Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefonicid sodium (Monocid).
    Med Lett Drugs Ther; 1984 Aug; 26(667):71-2. PubMed ID: 6379400
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefonicid concentrations in serum and atrial tissue during open-heart surgery.
    Sterling RP; Connor DJ; Norman JC; Cooley DA
    Antimicrob Agents Chemother; 1983 May; 23(5):790-2. PubMed ID: 6870226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.
    Chambers HF; Mills J; Drake TA; Sande MA
    Rev Infect Dis; 1984; 6 Suppl 4():S870-4. PubMed ID: 6522927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefonicid concentration in lung tissue after intramuscular administration.
    Cruciani M; Savio S; Concia E
    Int J Clin Pharmacol Res; 1987; 7(6):481-4. PubMed ID: 3440639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E; Brogden RN
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and myocardial levels of cefonicid during open-heart surgery.
    Sterling RP; Connor DJ; Norman JC
    J Natl Med Assoc; 1983 Nov; 75(11):1075-80. PubMed ID: 6655710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaphylatoxin in the aqueous humor of rabbit with endotoxin induced endophthalmitis].
    Kameda H; Fujiwara H; Katayama T; Suzuki T; Egi K; Goto S
    Nippon Ganka Gakkai Zasshi; 1989 Jan; 93(1):22-7. PubMed ID: 2665445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of cefonicid sodium in infusion fluids.
    Wong WW; Maderich AB; Polli GP; Ravin LJ
    Am J Hosp Pharm; 1985 Sep; 42(9):1980-3. PubMed ID: 4050816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of imipenem into human aqueous and vitreous humor.
    Axelrod JL; Newton JC; Klein RM; Bergen RL; Sheikh MZ
    Am J Ophthalmol; 1987 Dec; 104(6):649-53. PubMed ID: 3500645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of cefonicid in orthopedic surgery patients.
    Ackerman BH; Trang JM; Nelson CL; Pearce CE; Manning JT; Harrison BH
    Drug Intell Clin Pharm; 1988 Nov; 22(11):864-8. PubMed ID: 3234250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.